These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 33796946)
1. The value of asphericity derived from T1-weighted MR in differentiating intraparenchymal ring-enhancing lesions-comparison of glioblastomas and brain abscesses. Zeng T; Xu Z; Yan J Neurol Sci; 2021 Dec; 42(12):5171-5175. PubMed ID: 33796946 [TBL] [Abstract][Full Text] [Related]
2. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging. You SH; Yun TJ; Choi HJ; Yoo RE; Kang KM; Choi SH; Kim JH; Sohn CH Eur Radiol; 2018 Sep; 28(9):3801-3810. PubMed ID: 29619520 [TBL] [Abstract][Full Text] [Related]
3. Susceptibility-weighted imaging provides complementary value to diffusion-weighted imaging in the differentiation between pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors. Lai PH; Chung HW; Chang HC; Fu JH; Wang PC; Hsu SH; Hsu SS; Lin HS; Chuang TC Eur J Radiol; 2019 Aug; 117():56-61. PubMed ID: 31307653 [TBL] [Abstract][Full Text] [Related]
4. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI. Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047 [TBL] [Abstract][Full Text] [Related]
5. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient. Choi YS; Lee HJ; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK Eur Radiol; 2017 Apr; 27(4):1344-1351. PubMed ID: 27436023 [TBL] [Abstract][Full Text] [Related]
6. Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion. Bauer AH; Erly W; Moser FG; Maya M; Nael K Neuroradiology; 2015 Jul; 57(7):697-703. PubMed ID: 25845813 [TBL] [Abstract][Full Text] [Related]
7. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation. Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493 [TBL] [Abstract][Full Text] [Related]
8. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options. Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086 [TBL] [Abstract][Full Text] [Related]
9. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma. Lu S; Wang S; Gao Q; Zhou M; Li Y; Cao P; Hong X; Shi H J Comput Assist Tomogr; 2017; 41(6):898-903. PubMed ID: 28806317 [TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach. Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238 [TBL] [Abstract][Full Text] [Related]
11. Differentiating Primary Central Nervous System Lymphomas From Glioblastomas and Inflammatory Demyelinating Pseudotumor Using Relative Minimum Apparent Diffusion Coefficients. Wen JB; Huang WY; Xu WX; Wu G; Geng DY; Yin B J Comput Assist Tomogr; 2017; 41(6):904-909. PubMed ID: 28708728 [TBL] [Abstract][Full Text] [Related]
12. Histogram analysis based on diffusion kurtosis imaging: Differentiating glioblastoma multiforme from single brain metastasis and comparing the diagnostic performance of two region of interest placements. Gao E; Gao A; Kit Kung W; Shi L; Bai J; Zhao G; Cheng J Eur J Radiol; 2022 Feb; 147():110104. PubMed ID: 34972059 [TBL] [Abstract][Full Text] [Related]
13. Detection of soft-tissue abscess: Comparison of diffusion-weighted imaging to contrast-enhanced MRI. Chun CW; Jung JY; Baik JS; Jee WH; Kim SK; Shin SH J Magn Reson Imaging; 2018 Jan; 47(1):60-68. PubMed ID: 28432835 [TBL] [Abstract][Full Text] [Related]
14. True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis. Song YS; Choi SH; Park CK; Yi KS; Lee WJ; Yun TJ; Kim TM; Lee SH; Kim JH; Sohn CH; Park SH; Kim IH; Jahng GH; Chang KH Korean J Radiol; 2013; 14(4):662-72. PubMed ID: 23901325 [TBL] [Abstract][Full Text] [Related]
16. Comparison between the Prebolus T1 Measurement and the Fixed T1 Value in Dynamic Contrast-Enhanced MR Imaging for the Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Concurrent Radiation Therapy and Temozolomide Chemotherapy. Nam JG; Kang KM; Choi SH; Lim WH; Yoo RE; Kim JH; Yun TJ; Sohn CH AJNR Am J Neuroradiol; 2017 Dec; 38(12):2243-2250. PubMed ID: 29074633 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions. Kolakshyapati M; Hashizume A; Ochi K; Ueno H; Kaichi Y; Takayasu T; Takano M; Karlowee V; Akiyama Y; Awai K; Maruyama H; Sugiyama K; Kurisu K; Yamasaki F World Neurosurg; 2019 Nov; 131():e226-e236. PubMed ID: 31349079 [TBL] [Abstract][Full Text] [Related]
18. Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging. Ko CC; Tai MH; Li CF; Chen TY; Chen JH; Shu G; Kuo YT; Lee YC PLoS One; 2016; 11(9):e0162565. PubMed ID: 27631626 [TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: comparison with conventional MRI. Chang SC; Lai PH; Chen WL; Weng HH; Ho JT; Wang JS; Chang CY; Pan HB; Yang CF Clin Imaging; 2002; 26(4):227-36. PubMed ID: 12140151 [TBL] [Abstract][Full Text] [Related]
20. Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging. Kim R; Choi SH; Yun TJ; Lee ST; Park CK; Kim TM; Kim JH; Park SW; Sohn CH; Park SH; Kim IH Eur Radiol; 2017 Mar; 27(3):1176-1185. PubMed ID: 27357131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]